What products have broken ground in the digital therapeutics space, and how can they help patients?
There are several points along this pathway for a justice involved patient to be intercepted and diverted to mental health treatment.
Nearly half of the prescriptions for benzodiazepine among older adults are potentially inappropriate, so how best to do no harm?
Social anxiety disorder: increased screening and recognition are essential for proper diagnosis, and psychotropic and psychotherapeutic options can be effective.
Are you ready to understand how recovery-oriented cognitive therapy (CT-R) promotes wellness and empowerment for individuals experiencing serious mental health challenges? Check out this CME article.
“The pervasive feeling shared by all is that regardless of your personal journey and experiences with mental health, you are not alone.”
Available evidence from preclinical studies indicates that semaglutide shows promise for treating Alzheimer disease and Parkinson disease.
Simple but powerful strategies for drawing on patients’ existing character strengths and long-term goals.
In this CME article, learn how best to provide end-of-life care to patients with psychiatric disorders.
"Limiting definitions of recovery to abstinence and the absence of AUD symptoms fail to capture the multidimensional and heterogeneous pathways to recovery that research has shown to exist among both treatment-seeking and population samples."
“Freudian thought has massively influenced not only modern understandings of mind and therapeutic treatment, but also modernism and many distinct visions of politics.”
Here’s how a digital mental health ecosystem can seamlessly connect and support all facets of mental health care.
What are the greatest unmet mental health needs in the United States today? Recent statistics from the Centers for Disease Control may hold the answers.
The sympathy, empathy, and pure common sense of considering the intent and effect of the terms we use.
Contingency management is an effective behavior change technique commonly used to treat substance use disorders.
New approaches to ensure that the brain health technology sector continues to flourish for decades.
Two phase 3 trials were conducted to assess the clinical and biological effects as well as the safety of gantenerumab in individuals with mild cognitive impairment or mild dementia due to AD. Here's what you need to know.
This article provides a summary of key points discussed in a Case-Based Psych Perspectives Series, shared by Bryce Reynolds, MD, and Hannah Phillips-Hall, MSN, PMHNP-BC.
A psychiatric nurse practitioner shares gaps in care in bipolar 1 disorder treatment.
In this CME article, review literature on SRI-related bleeding complications in patients with GI bleeding, malignancy, perioperative settings, pregnancy, and hormonal therapy.
This comprehensive approach for assessing and addressing potential cardiac complications before prescribing psychotropics can enhance care.
Diagnosing this intricate comorbidity demands a nuanced approach. Here's what you need to know.
How effective are these agents for AUD treatment? An expert shares highlights from his 2024 ASCP Annual Meeting Pharmaceutical Pipeline Update presentation.
1 in 6 people with opioid use disorder experience a new traumatic event every month, but no evidence-based treatment for trauma.
In this CME article, learn more about a protocolized approach to the hospital management of pediatric patients with severe malnutrition related to eating disorders, including the utilization of a multidisciplinary care team and structured psychoeducation materials for families.
Mental health providers who battle a pandemic may find that it unsettles their deepest sense of self.
The emergence of epigenetic models has generated a surge of optimism, opening new possibilities for psychiatric intervention.
Petros Levounis, MD, MA, talks addiction, buprenorphine, his year as president of the APA, and more at the 2024 Annual Meeting.